Monoclonal Gammopathy of Undetermined Significance
41
12
16
11
Key Insights
Highlights
Success Rate
79% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
7.3%
3 terminated out of 41 trials
78.6%
-7.9% vs benchmark
0%
0 trials in Phase 3/4
45%
5 of 11 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 11 completed trials
Clinical Trials (41)
FAST-M: Prolonged Overnight Fasting and Mediterranean Dietary Intervention for Patients With Multiple Myeloma or Its Precursor Disease
Observational Prospective Research Study In Monoclonal Gammopathies leadINg to Myeloma
Promoting Diagnosis and Management of AL in Italy (ProDigALIty)
A Study Comparing a Plant-Based Diet With Supplements and Placebo in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
Two Biologically and Clinically Distinct Entities: Progressive Versus Stable Multiple Myeloma (MM) Precursor Conditions
MGUS/MM Awareness and Genetics Insights Campaign (MAGIC) Screening Study
Ohio State University Multiple Myeloma and Amyloidosis Data Registry and Sample Resource
Clonal Hematopoiesis of Immunological Significance
Investigation of Metformin for the Prevention of Progression of Precursor Multiple Myeloma
Imaging in MGUS, SMM and MM
Exploring the Effects of Korean-Style Mediterranean Diet (KORMED) and Physical Activity Measurement in Patients With MGUS/SMM: A Pilot Study
A Study of a Plant-Based Diet and Dietary Supplements in People With Smoldering Multiple Myeloma (SMM) or Monoclonal Gammopathy of Undetermined Significance (MGUS)
Sleep Apnea in Patients With MGUS and MM
Daratumumab for Polyneuropathy Associated With MGUS
Iceland Screens, Treats or Prevents Multiple Myeloma
A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)
Early Detection of Multiple Myeloma to Fight Cancer Disparities: A Screening and Patient Navigation Program
Determine the Frequency of Variants in the GBA/PSAP Genes in Patients With MM or MGUS
Whole Body MRI in Oncology